CD8A and neoplasm: For instance, DCs expressing FFAR2 inhibit their expression of IL-27 to sustain murine intestinal mucosal barrier integrity, reduce tumor bacterial burden, and suppress CD8+ T cell exhaustion, thereby restraining tumor initiation (102).